As an integrated pharmaceutical company, Acquire Pharmaceuticals offers a full range of pharmaceutical products from specialty chemicals to pharmaceutical intermediates and active pharmaceutical ingredients. With its establishment in 2021, we focus on developing complex molecules and commercializing them to address unmet demands in industries.
By combining technology, science, and innovation, we strive to create value-driven products tailored to our customers’ needs. We take pride in setting the products, processes and the systems as per the industry standards and in making continuous improvement to deliver quality products. Our facility is spread across an area of 2500 sq.m. with delineated areas for warehouse, QA, QC, R&D, production and finished products. The plant has current capacity of 250 KL and supported with clean rooms for finished products. As a part of our capacity expansion plan, our capacity would be approximately 500+ KL by 2027.
Backed by strong R&D, GMP & ISO certification. Ethical values and EHS standards are at the core of our business model. As developers of Active Pharmaceutical ingredients and intermediates, we work with innovators, generic companies, and partner exclusively as CMOs.

Acquire Pharmaceuticals

Org chart

Teams

Offices